Humanity is aspiring to transcend old age and death. In the 21st century, this might no longer be an unattainable dream.
With everyday exposure to news media, movies, novels and theater, it is easy to assume that artificial intelligence (AI) will be able to provide all-powerful machinery capable of solving matters such as birth, aging, sickness or death — but how far has AI actually progressed in terms of medical science?
As top medical journals show, the progress made by AI goes no further than the ability to more meticulously analyze retinal changes as a result of diabetes in angiographic images; more precisely identify melanoma in dermoscopy images; find lymph node metastasis through analyzing histopathology images of breast cancer patients more accurately and faster than pathologists; forecast blood sugar levels by making calculations based on human genes and gastrointestinal microbiota; and assist oncologists’ decisionmaking by providing more informed and concise suggestions for cancer treatment, an AI technology provided by IBM’s Watson for Oncology.
The IBM Watson after its launch in 2016 received polarized opinions following its failure at the University of Texas’ MD Anderson Cancer Center, with some considering its AI capacity to be immature.
However, the higher the expectations, the greater the disappointment when the technology fails.
Just like the aforementioned advanced medical applications for AI technology, the IBM Watson for Oncology is by no means all-encompassing. It was not designed to diagnose cancers, but to target seven kinds of cancer and provide more in-depth and specific treatment advice. It also cannot give advice on surgery and radiation therapy, nor can it offer suggestions to patients with cancer recurrence or metastasis.
It might sound as if the IBM Watson is useless and not nearly as miraculous as the public believes it to be, but when it comes to treating people diagnosed with early stages of one of the seven targeted kinds of cancer, it provides detailed suggestions for medication and treatment, including chemotherapy, targeted therapy and immunotherapy.
Its suggestions are not only in accordance with the therapy already under way, but it also offers new directions and, in some cases, therapeutic opinions.
Within the scope of its database, IBM Watson is knowledgeable and it keeps “studying” new findings from journals to enhance the precision and subtlety of its analyses.
If the question is whether AI technology can replace an outstanding oncologist, the answer is “of course not.” However, if the question is changed to “Will AI under certain circumstances be able to assist oncologists by providing more precise therapeutic opinions for cancer patients?” then the answer is probably “yes.”
Every time a new technology emerges, public expectations rise too high on the assumption that it will solve all current difficulties. In particular, people find it hard to resist imaginative temptation when it comes to a sexy phrase such as “artificial intelligence.” These wild fantasies often lead to what is known as “technology hype.”
In terms of AI applications in medicine, moderate technology hype could encourage entrepreneurs to make venture investments and bring new capital into the field, thus encouraging the world’s top 10 companies to put a large amount of funds and talent into research. After all, finding the solution to issues related to birth, aging, sickness and death is humankind’s Holy Grail and a tremendously huge business that is growing 10 percent annually.
However, generating too much hype might lead to disappointments and the end of investment and research.
To AI researchers, this scenario sounds all too familiar. Since its emergence, AI has experienced at least two cold spells, both of which began when the technology was over-hyped and bestowed with too many unattainable goals. The Fifth-Generation Computer Systems initiated by Japan, for instance, disappeared quietly into thin air.
The question is whether there will be a third “cold spell” following the most recent emergence. Nevertheless, this possibility looks slim, as the causes of the two previous cold spells have been thoroughly analyzed and their lessons have been learned.
If concise development goals can be established, more rational expectations kept and an early harvest list for specific fields set up beforehand, current hardware processing speed and software maturity mean that the risk for a third cold spell is not great.
In other words, the public might finally be able to enjoy the fruits of AI technology.
Jack Li is dean of Taipei Medical University’s College of Medical Science and founder of the Center for Artificial Intelligence for Medical and Health Innovation.
Translated by Chang Ho-ming
The narrative surrounding Indian Prime Minister Narendra Modi’s attendance at last week’s Shanghai Cooperation Organization (SCO) summit — where he held hands with Russian President Vladimir Putin and chatted amiably with Chinese President Xi Jinping (習近平) — was widely framed as a signal of Modi distancing himself from the US and edging closer to regional autocrats. It was depicted as Modi reacting to the levying of high US tariffs, burying the hatchet over border disputes with China, and heralding less engagement with the Quadrilateral Security dialogue (Quad) composed of the US, India, Japan and Australia. With Modi in China for the
The Jamestown Foundation last week published an article exposing Beijing’s oil rigs and other potential dual-use platforms in waters near Pratas Island (Dongsha Island, 東沙島). China’s activities there resembled what they did in the East China Sea, inside the exclusive economic zones of Japan and South Korea, as well as with other South China Sea claimants. However, the most surprising element of the report was that the authors’ government contacts and Jamestown’s own evinced little awareness of China’s activities. That Beijing’s testing of Taiwanese (and its allies) situational awareness seemingly went unnoticed strongly suggests the need for more intelligence. Taiwan’s naval
A report by the US-based Jamestown Foundation on Tuesday last week warned that China is operating illegal oil drilling inside Taiwan’s exclusive economic zone (EEZ) off the Taiwan-controlled Pratas Island (Dongsha, 東沙群島), marking a sharp escalation in Beijing’s “gray zone” tactics. The report said that, starting in July, state-owned China National Offshore Oil Corp installed 12 permanent or semi-permanent oil rig structures and dozens of associated ships deep inside Taiwan’s EEZ about 48km from the restricted waters of Pratas Island in the northeast of the South China Sea, islands that are home to a Taiwanese garrison. The rigs not only typify
Reading Lee Min-yung’s (李敏勇) article (“Taiwanese must unite to protect our nation,” Aug. 16, page 8) about Taiwan’s unfinished nationhood struck a chord with me. His reminder that Taiwan must raise its own banner of identity reminded me of my story as a Hong Konger born in the 1960s who lived through the loss of that very freedom. Hong Kong was ceded to the UK in 1842 and remained under British rule for 155 years. It grew from a fishing port into an international financial center — once dubbed the “Pearl of the Orient.” These achievements had nothing to do with
RSS